These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 23422867)
1. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial. Quaas AM; Kono N; Mack WJ; Hodis HN; Felix JC; Paulson RJ; Shoupe D Menopause; 2013 Aug; 20(8):840-4. PubMed ID: 23422867 [TBL] [Abstract][Full Text] [Related]
2. Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women. Alekel DL; Genschel U; Koehler KJ; Hofmann H; Van Loan MD; Beer BS; Hanson LN; Peterson CT; Kurzer MS Menopause; 2015 Feb; 22(2):185-97. PubMed ID: 25003624 [TBL] [Abstract][Full Text] [Related]
3. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Unfer V; Casini ML; Costabile L; Mignosa M; Gerli S; Di Renzo GC Fertil Steril; 2004 Jul; 82(1):145-8, quiz 265. PubMed ID: 15237003 [TBL] [Abstract][Full Text] [Related]
4. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Hodis HN; Mack WJ; Kono N; Azen SP; Shoupe D; Hwang-Levine J; Petitti D; Whitfield-Maxwell L; Yan M; Franke AA; Selzer RH; Stroke; 2011 Nov; 42(11):3168-75. PubMed ID: 21903957 [TBL] [Abstract][Full Text] [Related]
5. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Gull B; Karlsson B; Milsom I; Granberg S Am J Obstet Gynecol; 2003 Feb; 188(2):401-8. PubMed ID: 12592247 [TBL] [Abstract][Full Text] [Related]
6. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Murray MJ; Meyer WR; Lessey BA; Oi RH; DeWire RE; Fritz MA Menopause; 2003; 10(5):456-64. PubMed ID: 14501608 [TBL] [Abstract][Full Text] [Related]
7. Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women. Archer DF; Pinkerton JV; Utian WH; Menegoci JC; de Villiers TJ; Yuen CK; Levine AB; Chines AA; Constantine GD Menopause; 2009; 16(6):1109-15. PubMed ID: 19543129 [TBL] [Abstract][Full Text] [Related]
8. Long-term endometrial and breast safety of a specific, standardized soy extract. Palacios S; Pornel B; Vázquez F; Aubert L; Chantre P; Marès P Climacteric; 2010 Aug; 13(4):368-75. PubMed ID: 20380569 [TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. Pinkerton JV; Archer DF; Utian WH; Menegoci JC; Levine AB; Chines AA; Constantine GD Menopause; 2009; 16(6):1102-8. PubMed ID: 19546825 [TBL] [Abstract][Full Text] [Related]
10. Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Henderson VW; St John JA; Hodis HN; Kono N; McCleary CA; Franke AA; Mack WJ; Neurology; 2012 Jun; 78(23):1841-8. PubMed ID: 22665144 [TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
12. Endometrial safety of ospemifene: results of the phase 2/3 clinical development program. Constantine GD; Goldstein SR; Archer DF Menopause; 2015 Jan; 22(1):36-43. PubMed ID: 24977459 [TBL] [Abstract][Full Text] [Related]
13. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. Balk JL; Whiteside DA; Naus G; DeFerrari E; Roberts JM J Soc Gynecol Investig; 2002; 9(4):238-42. PubMed ID: 12113884 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Steinberg FM; Murray MJ; Lewis RD; Cramer MA; Amato P; Young RL; Barnes S; Konzelmann KL; Fischer JG; Ellis KJ; Shypailo RJ; Fraley JK; Smith EO; Wong WW Am J Clin Nutr; 2011 Feb; 93(2):356-67. PubMed ID: 21177797 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study. Palacios S; de Villiers TJ; Nardone Fde C; Levine AB; Williams R; Hines T; Mirkin S; Chines AA; Maturitas; 2013 Sep; 76(1):81-7. PubMed ID: 23871271 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling. Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P Am J Obstet Gynecol; 2020 Dec; 223(6):896.e1-896.e7. PubMed ID: 32640199 [TBL] [Abstract][Full Text] [Related]
17. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Fleischer AC; Wheeler JE; Lindsay I; Hendrix SL; Grabill S; Kravitz B; MacDonald B Am J Obstet Gynecol; 2001 Jan; 184(2):70-5. PubMed ID: 11174482 [TBL] [Abstract][Full Text] [Related]
18. Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy. Visser NC; Sparidaens EM; van den Brink JW; Breijer MC; Boss EA; Veersema S; Siebers AG; Bulten J; Pijnenborg JM; Bekkers RL Acta Obstet Gynecol Scand; 2016 Dec; 95(12):1418-1424. PubMed ID: 27633936 [TBL] [Abstract][Full Text] [Related]